These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11212751)

  • 1. [Severe combined immunodeficiency].
    Kumaki S; Tsuchiya S
    Ryoikibetsu Shokogun Shirizu; 2000; (32):38-42. PubMed ID: 11212751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe combined immunodeficiency].
    Okawa H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):235-9. PubMed ID: 9833479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe combined immunodeficiency diseases].
    Tsuchiya S
    Nihon Rinsho; 2005 May; 63 Suppl 5():565-9. PubMed ID: 15954410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe combined immunodeficiency disease and similar combined immunodeficiency disease].
    Nakata H; Mitsuya H
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():581-7. PubMed ID: 11808170
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the understanding and treatment of human severe combined immunodeficiency.
    Buckley RH
    Immunol Res; 2000; 22(2-3):237-51. PubMed ID: 11339359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
    Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
    J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.
    Laffort C; Le Deist F; Favre M; Caillat-Zucman S; Radford-Weiss I; Debré M; Fraitag S; Blanche S; Cavazzana-Calvo M; de Saint Basile G; de Villartay JP; Giliani S; Orth G; Casanova JL; Bodemer C; Fischer A
    Lancet; 2004 Jun; 363(9426):2051-4. PubMed ID: 15207958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of primary immunodeficiencies. Present and future].
    Serrano F; Laín de Lera T; González MA; García MJ; Abad JL; Bernad A
    Sangre (Barc); 1999 Apr; 44(2):143-53. PubMed ID: 10382324
    [No Abstract]   [Full Text] [Related]  

  • 9. [MHC class II deficiency (CIITA/RFX deficiency)].
    Morio T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):18-20. PubMed ID: 11212683
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunodeficiencies caused by genetic defects in protein kinases.
    Notarangelo LD
    Curr Opin Immunol; 1996 Aug; 8(4):448-53. PubMed ID: 8794005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe combined immunodeficiencies of the common gamma-chain/JAK3 signaling pathway.
    Schumacher RF; Notarangelo LD
    Isr Med Assoc J; 2002 Feb; 4(2):131-5. PubMed ID: 11875988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary CD4 deficiency].
    Yasukawa M
    Ryoikibetsu Shokogun Shirizu; 2000; (32):109-11. PubMed ID: 11212656
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe combined immunodeficiency--molecular pathogenesis and diagnosis.
    Gaspar HB; Gilmour KC; Jones AM
    Arch Dis Child; 2001 Feb; 84(2):169-73. PubMed ID: 11159300
    [No Abstract]   [Full Text] [Related]  

  • 14. Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency.
    Lai SY; Molden J; Goldsmith MA
    J Clin Invest; 1997 Jan; 99(2):169-77. PubMed ID: 9005984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective single-center study of clinical presentation and outcome in 117 patients with severe combined immunodeficiency.
    Stephan JL; Vlekova V; Le Deist F; De Saint Basile G; Donadieu J; Durandy A; Blanche S; Griscelli C; Fischer A
    Immunodeficiency; 1993; 4(1-4):87-8. PubMed ID: 8167742
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary CD7 deficiency].
    Yasukawa M
    Ryoikibetsu Shokogun Shirizu; 2000; (32):112-3. PubMed ID: 11212657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Report of a rare immunodeficiency, JAK-3 protein deficiency].
    Mbou FM; Cattelain N; Villatte P; Monlouis M; Elana G
    Arch Pediatr; 2001 Jun; 8(6):666-7. PubMed ID: 11446191
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe immunodeficiency due to Jak 3 kinase deficiency].
    Boku S; Saijo K; Saito T
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):631-6. PubMed ID: 9081731
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization.
    Mella P; Imberti L; Brugnoni D; Pirovano S; Candotti F; Mazzolari E; Bettinardi A; Fiorini M; De Mattia D; Martire B; Plebani A; Notarangelo LD; Giliani S
    Clin Immunol; 2000 Apr; 95(1 Pt 1):39-50. PubMed ID: 10794431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.
    Bunting KD; Lu T; Kelly PF; Sorrentino BP
    Hum Gene Ther; 2000 Nov; 11(17):2353-64. PubMed ID: 11096440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.